当前位置: X-MOL 学术Life Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line
Life Sciences ( IF 6.1 ) Pub Date : 2020-11-18 , DOI: 10.1016/j.lfs.2020.118796
Wei Yang , Jianhua Liu , Lin Hou , Qingmin Chen , Yahui Liu

Aims

In tumor cells, shikonin treatment has been reported to inhibit glycolysis by suppressing the activity of pyruvate kinase M2 (PKM2) and to induce apoptosis by increasing reactive oxygen species (ROS) production. However, hepatocellular carcinoma (HCC) shows variable sensitivity to shikonin treatment, and the mechanism for these differences remains unclear. We evaluated the effects of shikonin on metabolic and oxidative pathways in sensitive and refractory HCC cell lines to identify mechanisms of differential sensitivity.

Main methods

Cell viability and apoptosis were evaluated by MTT assay, PI/Annexin V and JC-1 staining. Mitochondrial function was further evaluated by measurements of ROS and mitochondrial mass. Oxygen consumption rates, NAD+/NADH, ATP and lactate were measured as indicators of energy metabolism and glycolysis. Protein expression associated with glycolysis and apoptosis was evaluated by western blotting, RT-qPCR and immunofluorescence staining.

Key findings

The sensitivity to shikonin treatment was significantly higher for HepG2 cells than for HCCLM3 cells, with less dramatic effects in HCCLM3 cells on apoptosis, ROS, and oxidative phosphorylation. Shikonin up-regulated mitochondrial biogenesis to increase mitochondrial oxidative phosphorylation in HepG2 cells, but displayed the opposite trend in HCCLM3 cells. Mechanistically, shikonin promoted nuclear expression of PKM2 and HIF1α in HCCLM3 cells, with upregulation of glycolysis-related gene transcription and glycolysis.

Significance

These results suggest that PKM2 rewires glucose metabolism, which explains the differential sensitivity to shikonin-induced apoptosis in HCC cells. Our findings elucidate mechanisms for differential responses to shikonin, provide potential biomarkers, and indicate a theoretical basis for targeting glycolytic enzymes in refractory HCC.



中文翻译:

紫草素通过PKM2和HIF1α差异调节葡萄糖代谢,以克服难治性HCC细胞株的凋亡

目的

在肿瘤细胞中,据报道,紫草素治疗可通过抑制丙酮酸激酶M2(PKM2)的活性来抑制糖酵解,并通过增加活性氧(ROS)的产生来诱导细胞凋亡。但是,肝细胞癌(HCC)对紫草素治疗表现出不同的敏感性,这些差异的机制仍不清楚。我们评估了紫草素对敏感和难治性HCC细胞系中代谢和氧化途径的影响,以确定差异敏感性的机制。

主要方法

通过MTT测定,PI / Annexin V和JC-1染色评估细胞活力和凋亡。通过测量ROS和线粒体质量进一步评估线粒体功能。测量耗氧率,NAD + / NADH,ATP和乳酸作为能量代谢和糖酵解的指标。通过蛋白质印迹,RT-qPCR和免疫荧光染色评估与糖酵解和凋亡相关的蛋白质表达。

主要发现

HepG2细胞对紫草素治疗的敏感性明显高于HCCLM3细胞,而HCCLM3细胞对凋亡,ROS和氧化磷酸化的影响较小。紫草素上调HepG2细胞中的线粒体生物发生,以增加线粒体的氧化磷酸化,但在HCCLM3细胞中却显示出相反的趋势。从机理上讲,紫草素通过上调糖酵解相关基因的转录和糖酵解,促进了HCCLM3细胞中PKM2和HIF1α的核表达。

意义

这些结果表明,PKM2重新改变了葡萄糖的代谢,这解释了紫草素诱导的HCC细胞凋亡的敏感性不同。我们的发现阐明了对紫草素差异反应的机制,提供了潜在的生物标记,并为靶向难治性肝癌中糖酵解酶提供了理论基础。

更新日期:2020-12-01
down
wechat
bug